Despite a high susceptibility of XIAP-deficient T cells to cell death after activation, EBV infection causes pathologies only in a third of XLP-2 patients and no EBV-associated lymphoproliferative diseases have so far been reported [2, 3, 27, 34–37]. This evidence concerns the gene XIAP and X-linked lymphoproliferative disease.